| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/030097498440859 |
| P698 | PubMed publication ID | 9645418 |
| P2093 | author name string | Horiuchi A | |
| Enomoto H | |||
| Ikoma S | |||
| Funauchi M | |||
| P2860 | cites work | Interleukin 4 induces changes in the chromatin structure of the gamma 1 switch region in resting B cells before switch recombination | Q36352086 |
| Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus | Q36984523 | ||
| Lymphokine production by human T cells in disease states | Q40661109 | ||
| Interleukin-12 and its role in the generation of TH1 cells | Q40712406 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Selection of a human T helper type 1-like T cell subset by mycobacteria | Q36230339 | ||
| P433 | issue | 3 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 219-224 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus | |
| P478 | volume | 27 |
| Q78555853 | Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity |
| Q75420192 | Anti-cardiolipin antibodies in atopic dermatitis |
| Q84996896 | Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes |
| Q37189357 | Association of estrogen receptor alpha gene polymorphisms with cytokine genes expression in systemic lupus erythematosus. |
| Q80830245 | Association of interferon-gamma gene polymorphism (+874A) with arthritis manifestation in SLE |
| Q101038873 | Atherosclerotic plaque vulnerability is increased in mouse model of lupus |
| Q77711918 | B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression |
| Q51016561 | CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients. |
| Q44400621 | Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4. |
| Q35079054 | Clinical applications of cytokine assays. |
| Q58192318 | Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus |
| Q37776658 | Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus |
| Q36659210 | Cytokines in systemic lupus erythematosus |
| Q43907857 | Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy |
| Q74254809 | Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus |
| Q28348358 | Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation |
| Q36537018 | Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis |
| Q73816096 | Differential effects of interleukin-4 in peptide induced autoimmunity |
| Q36245748 | Effect of pregnancy on serum cytokines in SLE patients |
| Q85232822 | Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis |
| Q31389226 | Enhanced tryptophan degradation in systemic lupus erythematosus |
| Q40475642 | Evaluation of systemic lupus erythematosus activity during pregnancy. |
| Q48070506 | Exercise training can attenuate the inflammatory milieu in women with systemic lupus erythematosus |
| Q36464913 | Genetic analysis of TNFST15 variants in ankylosing spondylitis |
| Q46643926 | High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage |
| Q91877314 | High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways |
| Q47999940 | IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. |
| Q73816093 | IL-4 and many roads to lupuslike autoimmunity |
| Q74169454 | Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody |
| Q35146924 | Immunobiologic consequences of assist devices |
| Q34506484 | Immunomodulation by metals |
| Q36287538 | Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases |
| Q44201018 | In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. |
| Q44271708 | In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation |
| Q35747810 | Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus |
| Q73310096 | Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) |
| Q42484085 | Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system |
| Q35160125 | Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications |
| Q37073886 | Interleukin-35: odd one out or part of the family? |
| Q33508917 | Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis |
| Q92816853 | Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects |
| Q28344436 | Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance |
| Q57350902 | Longitudinal study of interleukin-10, tumor necrosis factor- α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease |
| Q73154484 | Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus |
| Q78871135 | Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies |
| Q46130571 | Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus |
| Q81973156 | Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis |
| Q46304821 | Polarization of T Lymphocytes Is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB/c Mice |
| Q80539953 | Polymorphisms of genes for programmed cell death 1 ligands in patients with rheumatoid arthritis |
| Q36148820 | Salivary Interferon Gamma and Interleukin-4 Levels in Patients Suffering from Oral Lichen Planus. |
| Q77838746 | Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis |
| Q43212382 | Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus |
| Q28080245 | Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation |
| Q44490557 | Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. |
| Q33809561 | Systemic Lupus Erythematosus and Thyroid Autoimmunity |
| Q52932398 | T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. |
| Q47981648 | T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice. |
| Q37929551 | Th subset balance in lupus nephritis |
| Q53119004 | Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. |
| Q47134266 | The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases |
| Q74307371 | The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome |
| Q35294513 | The dysregulation of cytokine networks in systemic lupus erythematosus |
| Q73895339 | The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus |
| Q37504701 | The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus |
| Q34148661 | The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). |
| Q35809422 | Transcriptional regulation of interleukin 2 in SLE T cells |
| Q36951009 | Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. |
Search more.